Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Opiant Pharmaceuticals Inc (OPNT)

Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Opiant Pharmaceuticals Inc 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 USA

www.opiant.com P: 310-598-5410 F: 917-322-2105

Description:

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 106,641
Enterprise Value, $K 53,781
Shares Outstanding, K 5,164
Annual Sales, $ 47,790 K
Annual Net Income, $ 3,010 K
Last Quarter Sales, $ 170 K
Last Quarter Net Income, $ -9,920 K
60-Month Beta 0.84
% of Insider Shareholders 25.15%
% of Institutional Shareholders 42.39%
Float, K 3,865
% Float 74.85%
Short Volume Ratio 0.37

Growth:

1-Year Return -28.79%
3-Year Return 70.80%
5-Year Return 1.77%
5-Year Revenue Growth 159.02%
5-Year Earnings Growth 112.47%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.93 on 11/14/22
Next Earnings Date 03/21/23
Earnings Per Share ttm -6.56
EPS Growth vs. Prev Qtr 16.45%
EPS Growth vs. Prev Year -444.64%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 09/10/12
Dividend Payable Date 09/26/12
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 01/05/15

OPNT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -97.03%
Return-on-Assets % -59.66%
Profit Margin % 6.30%
Debt/Equity 0.60
Price/Sales 6.54
Price/Cash Flow 24.75
Price/Book 5.20
Book Value/Share 3.97
Interest Coverage 2.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar